Immugenia Inc.
Developing the next generation CAR therapy using hemopoietic stem cells to treat cancer and prevent relapses.
3 employees · est. 2022
TriSalus Life Sciences
An immunotherapy company working to improve the lives of patients living with liver and pancreatic tumors
114 employees · est. 2009 · Westminster, United States
TriSalus Life Sciences is the older company (2022 vs 2009); TriSalus Life Sciences is the larger of the two.
Side-by-Side Comparison
| Metric | Immugenia Inc. | TriSalus Life Sciences |
|---|---|---|
| Founded | ||
| Founded | 2022 | 2009 older |
| Headquarters | ||
| Headquarters | Not tracked yet | Westminster, United States |
| Employees | ||
| Employees | 3 | 114 larger |
| Industry | ||
| Industry | Biotechnology, Health and Wellness | Biotechnology, Hardware, Platforms |
| Funding Stage | ||
| Funding Stage | Pre Seed | Post Ipo Debt |
| Total Funding | ||
| Total Funding | Not tracked yet | $125.65M |
| Funding Rounds | ||
| Funding Rounds | 1 | 6 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | CAR Therapy, Immuno-oncology, Hematological Tumors, Solid Tumors, Hematopoietic Stem Cells, Cancer Treatment, Relapse Prevention, Immune System, T Cells, NK Cells, Specific Promoters, Cancer Therapy, Oncology, Preclinical Stage, Engineered Cells | Immunotherapy, Oncology, Drug Delivery Technology, Liver Tumors, Pancreatic Tumors, Cancer Treatment, Precision Medicine, Clinical Trials, Patient-focused, Innovation, Therapeutic Solutions |
| Website | ||
| Website | immugenia.com | trisaluslifesci.com |
About Immugenia Inc.
Immugenia Inc. is a preclinical stage immuno-oncology company founded in 2022, with a mission to develop the next generation CAR therapy for the treatment and prevention of relapses in hematological and solid tumors. The company's proprietary technology involves engineering hematopoietic stem cells...
About TriSalus Life Sciences
TriSalus Life Sciences is an oncology company founded in 2009 that focuses on integrating novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors. Their slogan "An immunotherapy company working to improve the lives of patients living with liv...
We will tell you when either one moves
BounceWatch watches Immugenia Inc. and TriSalus Life Sciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Immugenia Inc. and TriSalus Life Sciences — by email.
Frequently Asked Questions
Compare Immugenia Inc. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Immugenia Inc. on 12 Sep 2024, and TriSalus Life Sciences on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
